
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
Keywords: CT antigen; MAGE-A4; Cancer vaccine; Prognosis; MHC; Monitoring;